Enlon (edrophonium chloride injection), an acetylcholinesterase inhibitor, and Enlon-Plus (edrophonium chloride and atropine sulfate), an acetylcholinesterase inhibitor plus an anticholinergic, will be made available soon by Bioniche Pharma. Bioniche purchased the rights and certain assets related to the Enlon product line from Baxter, which discontinued Enlon in February 2008.

Enlon is expected to be available in 15mL vials (10mg/mL) and Enlon-Plus in 15mL vials, in addition to the 5mL ampule already on the market.

For more information call (888) 258-4199 or visit www.bionichepharmausa.com.